Mogamulizumab-associated rash: A challenging case report and literature review

Australas J Dermatol. 2023 May;64(2):e191-e193. doi: 10.1111/ajd.14022. Epub 2023 Mar 10.

Authors

Sandra Martínez-Fernández^{1

2}, Hae-Jin Suh-Oh^{1

2}, Carmen Couselo-Rodríguez^{1

2}, Diego Soto-García^{1

2}, Carlos Álvarez^{2

3}, Ángeles Flórez^{1

2}

Affiliations

¹ Department of Dermatology, Pontevedra University Hospital, Pontevedra, Spain.
² DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Pontevedra, Spain.
³ Department of Pathology, Pontevedra University Hospital, Pontevedra, Spain.

PMID: 36896897
DOI: 10.1111/ajd.14022

No abstract available

Keywords: Sézary syndrome; cutaneous T-cell lymphoma; drug-related side effect; mogamulizumab; mycosis fungoides; rash; recurrence.

Publication types

Review
Case Reports

MeSH terms

Exanthema* / chemically induced
Humans
Lymphoma, T-Cell, Cutaneous*
Mycosis Fungoides*
Sezary Syndrome*
Skin Neoplasms*

Substances

mogamulizumab